NCT01095003 2022-04-28
Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer
Pierre Fabre Medicament
Phase 3 Completed
Clinical Trials
5 trialsNCT01091168 2019-09-16
Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer
Pierre Fabre Medicament
Phase 3 Completed
NCT01953003 2019-05-02
Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
Pierre Fabre Medicament
Phase 3 Completed
NCT00450515 2016-12-06
Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Withdrawn
NCT00284180 2013-08-09
Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer
SCRI Development Innovations, LLC
Phase 2 Completed